Paul Sidoti is an Ophthalmology physician affiliated with New York Eye and Ear Infirmary. OpenAlex indexes 93 publications with 2,732 citations (h-index 28); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
310 East 14th Street
Suite 319s
New York, NY 10003
Telephone
212-979-4590Registry record last updated 15 Jan 2013.
Clinical trials
- Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
Sponsor: Aeon Astron Europe B.V.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20252 payments
- Glaukos CorporationProgram year20251 payment
- Alcon Vision LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
86.2%Prostaglandin Analog31.2%Latanoprost71%Lumigan21%Zioptan3%Travoprost2%Travatan Z2%Part D<11 patientsCarbonic Anhydrase Inhibitor26.9%Dorzolamide-Timolol60%Dorzolamide Hcl16%Cosopt Pf11%Brinzolamide9%Simbrinza4%Part D<11 patients+ 7 more classes in this area
Cardiovascular
6.7%Beta blocker6.7%Timolol Maleate100%Part D≥34 patientsNervous system
4.1%Cholinergic Receptor Agonist4.1%Pilocarpine Hcl100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Kupersmith, MD
New York Eye and Ear Infirmary
Janet Serle, MD
New York Eye and Ear Infirmary
Ronald Gentile, MD
New York Eye and Ear Infirmary
Kateki Vinod, MD
New York Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”